TrialInternational journal of clinical oncology2011

Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes.

Yoshihiro Matsubara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.